Nishimura Yasuharu | Department Of Immunogenetics Graduate School Of Medical Sciences Kumamoto University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

High Ratio of Myeloid Dendritic Cells to Plasmacytoid Dendritic Cells in Blood of Patients With Acute Coronary Syndrome
Specificity, degeneracy, and molecular mimicry in antigen recognition by HLA-Class II restricted T cell receptors : implications for clinical medicine
Identification of the H2-K^d-restricted cytotoxic T lymphocyte epitopes of a tumor-associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice
Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo
DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4^+ T cells and CD8^+ T cells
Nature of T cell recognition of self -and nonself-peptides : its implication to anti-tumor immunity
Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients
Elevated Plasma Osteopontin Levels Were Associated With Osteopontin Expression of CD4^+ T Cells in Patients With Unstable Angina
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population
Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
QHLA-DQ-binding peptide motifs. I. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplobypes
Pluripotent stem cells as source of dendritic cells for immune therapy
Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc^ mice
Therapeutic effect of α-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells
Modification of Human T-Cell Responses by Altered Peptide Ligands: A New Approach to Antigen-specific Modification
Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells

もっと見る

スポンサーリンク